PATHOGENESIS AND POTENTIAL STRATEGIES FOR PREVENTION AND TREATMENT OF SEPTIC SHOCK - AN UPDATE

被引:70
作者
GLAUSER, MP
HEUMANN, D
BAUMGARTNER, JD
COHEN, J
机构
[1] HAMMERSMITH HOSP, DEPT INFECT DIS, LONDON, ENGLAND
[2] HAMMERSMITH HOSP, DEPT BACTERIOL & MED, LONDON, ENGLAND
[3] ROYAL POSTGRAD MED SCH, LONDON, ENGLAND
关键词
D O I
10.1093/clinids/18.Supplement_2.S205
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Septic shock is mediated by complex interactions of cells, cytokines, and humoral pathways. Clinical therapeutic strategies aimed at inhibiting selected pathways have been efficacious in subsets of patients. Experimental studies focusing on the activities of single cytokines have contributed to the understanding of the complex pathophysiology of septic shock. More precise delineation of the roles of each mechanism contributing to pathogenesis will permit the identification of subsets of patients who might benefit from particular therapeutic strategies and will guide the development of additional approaches to prevention and treatment.
引用
收藏
页码:S205 / S216
页数:12
相关论文
共 107 条
[1]   A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BURESH, CM ;
VENZON, DJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032
[2]  
ANDERSON BO, 1991, SURG GYNECOL OBSTET, V172, P415
[3]   PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].
ASHKENAZI, A ;
MARSTERS, SA ;
CAPON, DJ ;
CHAMOW, SM ;
FIGARI, IS ;
PENNICA, D ;
GOEDDEL, DV ;
PALLADINO, MA ;
SMITH, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539
[4]   DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS [J].
BAGBY, GJ ;
PLESSALA, KJ ;
WILSON, LA ;
THOMPSON, JJ ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :83-88
[5]  
Baumgartner J D, 1991, Infect Dis Clin North Am, V5, P915
[6]   ANTIBODIES TO LIPOPOLYSACCHARIDES AFTER IMMUNIZATION OF HUMANS WITH THE ROUGH MUTANT ESCHERICHIA-COLI J5 [J].
BAUMGARTNER, JD ;
HEUMANN, D ;
CALANDRA, T ;
GLAUSER, MP .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :769-772
[7]   ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTI-LIPOPOLYSACCHARIDE (LPS) ANTIBODIES AND SUPPRESSION OF LPS-INDUCED TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-6 [J].
BAUMGARTNER, JD ;
HEUMANN, D ;
GERAIN, J ;
WEINBRECK, P ;
GRAU, GE ;
GLAUSER, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :889-896
[8]  
BAUMGARTNER JD, 1985, LANCET, V2, P59
[9]   INVITRO STIMULATION OF TNF-ALPHA FROM HUMAN WHOLE-BLOOD BY CELL-FREE SUPERNATANTS OF GRAM-POSITIVE BACTERIA [J].
BAYSTON, K ;
TOMLINSON, M ;
COHEN, J .
CYTOKINE, 1992, 4 (05) :397-402
[10]   GAMMA-INTERFERON - THE MATCH THAT LIGHTS THE FIRE [J].
BILLIAU, A .
IMMUNOLOGY TODAY, 1988, 9 (02) :37-40